| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/02/2009 | US20090170901 Benzoyl Urea Derivatives |
| 07/02/2009 | US20090170900 Dosing regimen for weight loss |
| 07/02/2009 | US20090170899 Stimulators of 5-HT4 receptors and uses thereof |
| 07/02/2009 | US20090170898 Sulphonamide Derivatives as Modulators of the Glucocorticoid Receptor |
| 07/02/2009 | US20090170897 Method of Treating Neuropathic Pain |
| 07/02/2009 | US20090170896 c-Met modulators and methods of use |
| 07/02/2009 | US20090170895 S1p3 receptor antagonist |
| 07/02/2009 | US20090170894 Urea derivatives of tropane, their preparation and their therapeutic application |
| 07/02/2009 | US20090170893 Novel hydrate form |
| 07/02/2009 | US20090170892 3-Hydroxy-6-phenylphenanthridines as pde4 inhibitors |
| 07/02/2009 | US20090170891 Niacin Receptor Agonists, Compositions Containing Such Compounds and Methods of Treatment |
| 07/02/2009 | US20090170890 Methohds of inhibiting viral infection |
| 07/02/2009 | US20090170889 Use of finasteride, dutasteride and related compounds for the prevention or treatment of neurologically-associated disorders |
| 07/02/2009 | US20090170888 Antipruritic Agent for Pruritus Caused by Multiple Sclerosis |
| 07/02/2009 | US20090170887 Novel indazole derivative having spiro ring structure in side chain |
| 07/02/2009 | US20090170886 4-[(3-hydroxybenzyl)oxy]-2-(trifluoromethyl)benzonitrile; selective androgen receptor modulators; decrease excess sebum secretions; stimulants of hair growth at higher rates of cosmetically acceptable hair growth in patients with alopecia; acne; skin disorders; prostate cancer |
| 07/02/2009 | US20090170885 Naphthyridine derivatives as potassium channel modulators |
| 07/02/2009 | US20090170883 3-arylphenyl sulfide derivative and insecticide and miticide |
| 07/02/2009 | US20090170882 Methods and compositions |
| 07/02/2009 | US20090170881 New inhibitors of histone deacetylase |
| 07/02/2009 | US20090170880 Methods and Means for the Treatment of Cancer |
| 07/02/2009 | US20090170879 6,9-Disubstituted Purine Derivatives and Their Use as Cosmetics and Cosmetic Compositions |
| 07/02/2009 | US20090170878 Macrocyclic compounds useful as bace inhibitors |
| 07/02/2009 | US20090170877 5,6-Trimethylenepyrimidin-4-one compounds |
| 07/02/2009 | US20090170876 Novel Topical Formulations of Flucytosine |
| 07/02/2009 | US20090170875 Compounds for the treatment of inflammatory disorders |
| 07/02/2009 | US20090170874 Triazole-substituted arylamides as P2X3 and P2X2/3 antagonists |
| 07/02/2009 | US20090170873 Pyrazole-substituted arylamides as P2X3 and P2X2/3 antagonists |
| 07/02/2009 | US20090170872 Compounds and Their Pharmaceutical Use |
| 07/02/2009 | US20090170871 IL-8 Receptor Antagonists |
| 07/02/2009 | US20090170870 Amidine-containing compounds useful as muscarinic receptor antagonists |
| 07/02/2009 | US20090170869 Piperazine derivative having affinity for the histamine h3 receptor |
| 07/02/2009 | US20090170868 Trpv1 antagonists including dihydroxy substituent and uses thereof |
| 07/02/2009 | US20090170867 Trpv1 antagonists including sulfonamide substituent and uses thereof |
| 07/02/2009 | US20090170866 Moesin, caveolin 1 and yes associated protein 1 as predictive markers of response to dasatinib in breast cancers |
| 07/02/2009 | US20090170865 Treatment of Prostate Cancer with Angiogenesis-Targeting Quinazoline-Based Anti-Cancer Compounds |
| 07/02/2009 | US20090170864 (S)-3-{5-[(1-Pyridin-2-yl-3-trifluoromethyl-1H-pyrazole-4-carbonyl)-amino]-pyridin-2-ylamino}-pyrrolidine-1-carboxylic acid ethyl ester; obesity, type II diabetes mellitus and metabolic syndrome |
| 07/02/2009 | US20090170863 Acylated Spiropiperidine Derivatives as Melanocortin-4 Receptor Modulators |
| 07/02/2009 | US20090170862 Use of c-kit inhibitors for the treatment of myeloma |
| 07/02/2009 | US20090170861 Pyridazinone Derivatives Useful as Glucan Synthase Inhibitors |
| 07/02/2009 | US20090170860 Use of PARP-1 Inhibitors |
| 07/02/2009 | US20090170859 Viral Polymerase Inhibitors |
| 07/02/2009 | US20090170858 Methods and Compositions Containing Natural Folates for Protecting Against Radiation Damage |
| 07/02/2009 | US20090170857 Method for healing a wound using a direct vasodilator |
| 07/02/2009 | US20090170856 Heterocyclic antiviral compounds |
| 07/02/2009 | US20090170855 Hiv inhibiting 3,4-dihydro-imidazo[4,5-b]pyridin-5-ones |
| 07/02/2009 | US20090170854 New Use |
| 07/02/2009 | US20090170853 4-(4-Fluoro-2-methyl-1H-indol-5-yloxy)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-ol; inhibit the tyrosine kinase activity of endothelial and fibroblast growth factors receptors; angiogenesis inhibitor; anticarcinogenic agent (hepatocellular cancer, colorectal cancer or non-small cell lung cancer) |
| 07/02/2009 | US20090170852 NOVEL PYRAZOLE-BASED HMG CoA REDUCTASE INHIBITORS |
| 07/02/2009 | US20090170851 Chroman Compounds |
| 07/02/2009 | US20090170850 Cycloalkyl derivatives of 3-hydroxy-4-pyridinones |
| 07/02/2009 | US20090170849 Quinazolinone derivatives having b-raf inhibitory activity |
| 07/02/2009 | US20090170848 Thiazolones for use as pi3 kinase inhibitors |
| 07/02/2009 | US20090170847 Imidazopyridine Derivatives Inhibiting Protein Kinase Activity, Method for the Preparation Thereof and Pharmaceutical Composition Containing Same |
| 07/02/2009 | US20090170846 Inhibitors of the hiv integrase enzyme |
| 07/02/2009 | US20090170845 USE OF IMIDAZO[2,1-b]-1,3,4-THIADIAZOLE-2-SULFONAMIDE COMPOUNDS TO TREAT NEUROPATHIC PAIN |
| 07/02/2009 | US20090170844 Spiro Tetracyclic Compound |
| 07/02/2009 | US20090170843 podophyllotoxin derivatives such as (2-{3-[4-(3-aminopropylamino)-butylamino]-propylamino}-N-[9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5,6,8,8a,9-hexahydrofuro[3',4':6,7]naptho[2,3-d][1,3]dioxol-5-yl]-acetamide, used as anticarcinogenic agents |
| 07/02/2009 | US20090170842 Brca1-based breast or ovarian cancer prevention agents and methods of use |
| 07/02/2009 | US20090170841 Styrenyl Derivative Compounds for Treating Ophthalmic Diseases and Disorders |
| 07/02/2009 | US20090170840 NS1 protein inhibitors |
| 07/02/2009 | US20090170839 Aerosol formulation for inhalation containing an anticholinergic agent |
| 07/02/2009 | US20090170838 Bicycloheteroaryl compounds as P2X7 modulators and uses thereof |
| 07/02/2009 | US20090170837 Methods for treating ras driven cancer in a subject |
| 07/02/2009 | US20090170836 New inhibitors of histone deacetylase |
| 07/02/2009 | US20090170835 Isoindoline derivatives |
| 07/02/2009 | US20090170834 Fused Pyrimidones and Thiopyrimidones, and Uses Thereof |
| 07/02/2009 | US20090170833 Pyrazolyl derivatives, preparation process and intermediates of this process as medicinal products and pharmaceutical compositions containing them |
| 07/02/2009 | US20090170832 HETEROCYCLIC COMPOUNDS HAVING TYPE I 11beta HYDROXYSTEROID DEHYDROGENASE INHIBITORY ACTIVITY |
| 07/02/2009 | US20090170831 Substituted lactams as inhibitors of abeta protein production |
| 07/02/2009 | US20090170830 Tricyclic Beta-Secretase Inhibitors for the Treatment of Alzheimer's Disease |
| 07/02/2009 | US20090170829 Carboxamide, Sulfonamide and Amine Compounds and Methods for Using The Same |
| 07/02/2009 | US20090170828 Azetidine Derivatives as Inhibitors of Stearoyl-Coenzyme a Delta-9 Desaturase |
| 07/02/2009 | US20090170827 Acid Addition Salt of Dihydropyridine Derivative |
| 07/02/2009 | US20090170826 Acid Addition Salt of Optically Active Dihydropyridine Derivative |
| 07/02/2009 | US20090170825 Beta-lactamylalkanoic acids for treating premenstrual disorders |
| 07/02/2009 | US20090170824 Diarylsulfones as 5-HT2A Antagonists |
| 07/02/2009 | US20090170823 Dosage Regimens and Pharmaceutical Compositions and Packages for Emergency Contraception |
| 07/02/2009 | US20090170822 2-Methylene-20-Methyl-19,24,25,26,27-Pentanor-Vitamin D Analogs |
| 07/02/2009 | US20090170821 2-Methylene-(20S,25S)-19,26-Dinor-Vitamin D Analogs |
| 07/02/2009 | US20090170820 2-Methylene-(20S,25R)-19,26-Dinor-Vitamin D Analogs |
| 07/02/2009 | US20090170819 (20R)-23,23-Difluoro-2-Methylene-19-Nor-Bishomopregnacalciferol-Vitamin D Analogs |
| 07/02/2009 | US20090170818 Arresting the proliferation of undifferentiated cells and inducing their differentiation; anticancer agents; treating psoriasis, wrinkles, slack skin, dry skin, insufficient sebum secretion, autoimmune disorders, inflammatory diseases, renal osteodystrophy. and obesity; little, if any, calcemic activity |
| 07/02/2009 | US20090170816 Combination comprising squalene, a phospholipid and an omega 3 fatty acid for the treatment of cancer |
| 07/02/2009 | US20090170815 Alendronate oral liquid formulations |
| 07/02/2009 | US20090170814 Neurodegenerative disorders; antiinflammatory agents; antiischemic agents; neuropathic pain; antiepileptic agents; Parkinson's disease; Alzheimer's disease; antidiabetic agents; 3-(6-Hydroxy-2-methyl-3,4,7,8,9,10-hexahydro-7,10-methano-2H -benzo[h]chromen-2-yl)-propionic acid methyl ester |
| 07/02/2009 | US20090170813 Hypophosphorous Acid Derivatives and their Therapeutical Applications |
| 07/02/2009 | US20090170812 Transcription factor modulating compounds and methods of use thereof |
| 07/02/2009 | US20090170811 Composition for treatment of a detached retina and method of prodution thereof |
| 07/02/2009 | US20090170810 Methods of treatment of cardiovascular and cerebrovascular diseases with low molecular weight fucoidan |
| 07/02/2009 | US20090170809 Pectic Polysaccharides Isolated from Fruit Pods of Okra |
| 07/02/2009 | US20090170808 Oral agent for improving and protecting the function of joint comprising hyaluronic acid-phospholipid complexes |
| 07/02/2009 | US20090170807 Methods and means for producing hyaluronan |
| 07/02/2009 | US20090170806 Combination of alovudine and zidovudine in a molar ratio of 1:100 to 1:350 |
| 07/02/2009 | US20090170805 Anti-microbial agents and uses thereof |
| 07/02/2009 | US20090170804 Pirfenidone/toll-like receptor (tlr) agonist compositions and methods for using them to stimulate production of granulocyte colonizing stimulating factor (g-csf) |
| 07/02/2009 | US20090170803 Adjunctive treatment of biological diseases |
| 07/02/2009 | US20090170802 Method for producing polymers |
| 07/02/2009 | US20090170801 Methods of treatment of cardiovascular and cerebrovascular diseases with fucoidan |
| 07/02/2009 | US20090170800 Genetic constructs and compositions comprising rre and cte and uses thereof |